Company registration number 13473077 (England and Wales)
HOLOCARE LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED
30 JUNE 2025
PAGES FOR FILING WITH REGISTRAR
Kings House
9-10 Haymarket
London
United Kingdom
SW1Y 4BP
HOLOCARE LIMITED
CONTENTS
Page
Company information
1
Statement of financial position
2 - 3
Notes to the financial statements
4 - 7
HOLOCARE LIMITED
COMPANY INFORMATION
- 1 -
Directors
Dr Malcolm Luker
Ms Alison Sundset
Ms Solfrid Skilbrigt
Company number
13473077
Registered office
Kings House
9-10 Haymarket
London
United Kingdom
SW1Y 4BP
Accountants
TC Group London Limited
Kings House
9-10 Haymarket
London
United Kingdom
SW1Y 4BP
HOLOCARE LIMITED
STATEMENT OF FINANCIAL POSITION
AS AT
30 JUNE 2025
30 June 2025
- 2 -
2025
2024
Notes
£
£
£
£
Non-current assets
Property, plant and equipment
4
5
871
Current assets
Trade and other receivables
5
44,346
41,763
Cash and cash equivalents
5,334
11,663
49,680
53,426
Current liabilities
6
(33,013)
(38,562)
Net current assets
16,667
14,864
Net assets
16,672
15,735
Equity
Called up share capital
100
100
Retained earnings
16,572
15,635
Total equity
16,672
15,735
HOLOCARE LIMITED
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT
30 JUNE 2025
30 June 2025
- 3 -

For the financial year ended 30 June 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the income statement within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 21 August 2025 and are signed on its behalf by:
Dr Malcolm Luker
Director
Company registration number 13473077 (England and Wales)
HOLOCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2025
- 4 -
1
Accounting policies
Company information

Holocare Limited is a private company limited by shares incorporated in England and Wales. The registered office is Kings House, 9-10 Haymarket, London, United Kingdom, SW1Y 4BP.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.

1.2
Revenue

Revenue is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

1.3
Property, plant and equipment

Property, plant and equipment are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Computers
3 years straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Impairment of non-current assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

1.5
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

HOLOCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 JUNE 2025
1
Accounting policies
(Continued)
- 5 -
Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the income statement, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.6
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or non-current assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.7
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

HOLOCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 JUNE 2025
- 6 -
2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

 

In the opinion of the directors there are no significant judgements or areas of estimation uncertainty.

 

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
3
4
4
Property, plant and equipment
Plant and machinery etc
£
Cost
At 1 July 2024 and 30 June 2025
4,118
Depreciation and impairment
At 1 July 2024
3,247
Depreciation charged in the year
866
At 30 June 2025
4,113
Carrying amount
At 30 June 2025
5
At 30 June 2024
871
HOLOCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 JUNE 2025
- 7 -
5
Trade and other receivables
2025
2024
Amounts falling due within one year:
£
£
Trade receivables
13,500
-
0
Amounts owed by group undertakings
30,846
20,453
Other receivables
-
0
21,310
44,346
41,763
6
Current liabilities
2025
2024
£
£
Trade payables
3,602
-
0
Taxation and social security
333
2,657
Other payables
29,078
35,905
33,013
38,562
7
Related party transactions

During the year the company invoiced management fees and recharges of £184,810 (2024: £291,336) to its parent company, Holocare AS.

 

At 30 June 2025 the company was owed £30,846 (2024: £20,453 owed to) by its parent company, Holocare AS.

2025-06-302024-07-01falsefalsefalseCCH SoftwareCCH Accounts Production 2025.200No description of principal activityDr Malcolm LukerMs Alison SundsetMs Solfrid Skilbrigt134730772024-07-012025-06-3013473077bus:Director12024-07-012025-06-3013473077bus:Director22024-07-012025-06-3013473077bus:Director32024-07-012025-06-3013473077bus:RegisteredOffice2024-07-012025-06-30134730772025-06-30134730772024-06-3013473077core:OtherPropertyPlantEquipment2025-06-3013473077core:OtherPropertyPlantEquipment2024-06-3013473077core:CurrentFinancialInstrumentscore:WithinOneYear2025-06-3013473077core:CurrentFinancialInstrumentscore:WithinOneYear2024-06-3013473077core:CurrentFinancialInstruments2025-06-3013473077core:CurrentFinancialInstruments2024-06-3013473077core:ShareCapital2025-06-3013473077core:ShareCapital2024-06-3013473077core:RetainedEarningsAccumulatedLosses2025-06-3013473077core:RetainedEarningsAccumulatedLosses2024-06-3013473077core:ComputerEquipment2024-07-012025-06-30134730772023-07-012024-06-3013473077core:OtherPropertyPlantEquipment2024-06-3013473077core:OtherPropertyPlantEquipment2024-07-012025-06-3013473077core:WithinOneYear2025-06-3013473077core:WithinOneYear2024-06-3013473077bus:PrivateLimitedCompanyLtd2024-07-012025-06-3013473077bus:SmallCompaniesRegimeForAccounts2024-07-012025-06-3013473077bus:FRS1022024-07-012025-06-3013473077bus:AuditExempt-NoAccountantsReport2024-07-012025-06-3013473077bus:FullAccounts2024-07-012025-06-30xbrli:purexbrli:sharesiso4217:GBP